
|Slideshows|April 4, 2018
sTMS Device May Prevent Migraine
Author(s)Veronica Hackethal, MD
A study undertaken to evaluate the efficacy and tolerability of single pulse transcranial magnetic stimulation (sTMS) for the preventive treatment of migraine has led to an FDA extended indication.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Advancing the Field: Stem Cell Therapies and the Future of Parkinson Disease Treatment
2
Current and Emerging Strategies for Managing Huntington Disease Symptoms: Karen Anderson, MD
3
Improving Recognition and Treatment of Hyperkinetic Movement Disorders: Zoltan Mari, MD
4
Improving Stability with Advanced Therapies in Parkinson’s Disease
5














